Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12311995 | 0.77 | TP53 (0.34) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL796984 | 0.74 | SLC6A2 (0.35) | SLC6A2SLC6A4OPRM1SLC6A3 | |
| SCHEMBL7931565 | 0.70 | SLC6A2 (0.33) | SLC6A2SLC6A4OPRM1SLC6A3 | |
| SCHEMBL4560773 | 0.69 | SLC6A2 (0.46) | SLC6A2SLC6A4OPRM1SLC6A3 | |
| Oxalic Acid SCHEMBL2795491 | 0.69 | ALDH1A1 (0.38) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL595843 | 0.67 | ALDH1A1 (0.36) | ALDH1A1SLC6A2SLC6A4OPRM1SLC6A3 | |
| SCHEMBL8087696 | 0.65 | — | — | |
| SCHEMBL7676836 | 0.65 | SLC6A4 (0.36) | SLC6A2SLC6A4OPRM1SLC6A3 | |
| SCHEMBL1152813 | 0.65 | SLC6A4 (0.36) | SLC6A2SLC6A4OPRM1SLC6A3 | |
| SCHEMBL1661392 | 0.65 | SLC6A4 (0.36) | SLC6A2SLC6A4OPRM1SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8481652-B2 | Thermoplastic polyamides having polyether amines | BASF SE (DE) | 2013-07-09 | — | — | US | disclosed |
| WO-2012007301-A3 | FOAM ENHANCEMENT OF FATTY ACYL GLYCINATE SURFACTANTS | UNILEVER PLC (GB) | 2012-05-10 | — | — | WO | disclosed |
| EP-2257597-B1 | POLYAMIDE NANOCOMPOSITES WITH HYPER- BRANCHED POLYETHERAMINES | BASF SE (DE) | 2011-11-30 | — | — | EP | disclosed |
| EP-2227507-B1 | THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES | BASF SE (DE) | 2011-08-31 | — | — | EP | disclosed |
| US-20110021686-A1 | POLYAMIDE NANOCOMPOSITES WITH HYPER-BRANCHED POLYETHERAMINES | BASF SE (DE) | 2011-01-27 | — | — | US | disclosed |
| US-20110021687-A1 | POLYAMIDE NANOCOMPOSITES WITH HYPER-BRANCHED POLYETHYLENEIMINES | BASF SE (DE) | 2011-01-27 | — | — | US | disclosed |
| US-20110009566-A1 | THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES | BASF SE (DE) | 2011-01-13 | — | — | US | disclosed |
| EP-2257597-A2 | POLYAMIDE NANOCOMPOSITES WITH HYPER- BRANCHED POLYETHERAMINES | BASF SE (DE) | 2010-12-08 | — | — | EP | disclosed |
| EP-2254949-A1 | POLYAMIDE NANOCOMPOSITES WITH HYPER-BRANCHED POLYETHYLENIMINES | BASF SE (DE) | 2010-12-01 | — | — | EP | disclosed |
| EP-2227507-A2 | THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES | BASF SE (DE) | 2010-09-15 | — | — | EP | disclosed |
| WO-2010028975-A2 | THERMALLY CONDUCTIVE POLYAMIDE HAVING INCREASED FLOW CAPABILITY | BASF SE (DE) | 2010-03-18 | — | — | WO | disclosed |
| WO-2009115535-A2 | POLYAMIDE NANOCOMPOSITES WITH HYPER- BRANCHED POLYETHERAMINES | BASF SE (DE) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009115536-A1 | POLYAMIDE NANOCOMPOSITES WITH HYPER-BRANCHED POLYETHYLENIMINES | BASF SE (DE) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009077492-A2 | THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES | BASF SE (DE) | 2009-06-25 | — | — | WO | disclosed |
| WO-2009050094-A1 | THERMOPLASTIC POLYESTER MOLDING COMPOUNDS COMPRISING HIGHLY BRANCHED POLYETHER AMINES | BASF SE (DE) | 2009-04-23 | — | — | WO | disclosed |